Skip to main content
. 2015 May 27;15:433. doi: 10.1186/s12885-015-1459-7

Table 3.

Distribution of SNPs in IL-27 among NMIBC and MIBC patients

rs153109 rs17855750
Model Genotype NMIBC MIBC OR (95 % CI)a P valuea Genotype NMIBC MIBC OR (95 % CI)a P valuea
N = 176 (%) N = 156 (%) N = 176 (%) N = 156 (%)
Codominant AA 66 (37.5 %) 61 (39.1 %) 1.00 (reference) 0.99 TT 149 (84.7 %) 126 (80.8 %) 1.00 (reference) 0.076
AG 87 (49.4 %) 73 (46.8 %) 1.04 (0.60–1.81) TG 26 (14.8 %) 27 (17.3 %) 0.53 (0.26–1.09)
GG 23 (13.1 %) 22 (14.1 %) 1.02 (0.46–2.27) GG 1 (0.6 %) 3 (1.9 %) 0.15 (0.01–1.84)
Dominant AA 66 (37.5 %) 61 (39.1 %) 1.00 (reference) 0.88 TT 149 (84.7 %) 126 (80.8 %) 1.00 (reference) 0.042
AG/GG 110 (62.5 %) 95 (60.9 %) 1.04 (0.62–1.75) TG/GG 27 (15.3 %) 30 (19.2 %) 2.04 (1.024.17)
Recessive AA/AG 153 (86.9 %) 134 (85.9 %) 1.00 (reference) 0.99 TT/TG 175 (99.4 %) 153 (98.1 %) 1.00 (reference) 0.14
GG 23 (13.1 %) 22 (14.1 %) 1.00 (0.48–2.09) GG 1 (0.6 %) 3 (1.9 %) 0.17 (0.01–2.07)
Overdominant AA/GG 89 (50.6 %) 83 (53.2 %) 1.00 (reference) 0.88 TT/GG 150 (85.2 %) 129 (82.7 %) 1.00 (reference) 0.1
AG 87 (49.4 %) 73 (46.8 %) 1.04 (0.63–1.73) TG 26 (14.8 %) 27 (17.3 %) 0.55 (0.27–1.13)
Allele
A 219 (62.2) 195 (62.5) 0.99 (0.72–1.35) 0.94 T 324 (92.0) 279 (89.4) 1.37 (0.81–2.32) 0.28
G 133 (37.8) 117 (37.5) G 28 (8.0) 33 (10.6)

N corresponds to the number of individuals

aAdjusted by age, sex and smoking status

Boldfaced values indicate a significant difference at the 5 % level